A Prospective, Randomized, Open-Label, Parallel Trial Comparing the Efficacy of Α-Blocker or 5Α-Reductase Inhibitor Withdrawal to Continued Combination Therapy on the Maintenance of Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia.
European Urology（2024）
关键词
5-alpha reductase inhibitors,adrenergic alpha-1 receptor antagonists,lower urinary tract symptoms,prostatic hyperplasia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要